NEW YORK, Nov. 24, 2014 (GLOBE NEWSWIRE) -- Pfizer Inc. (Nasdaq: Pfizer) today announced that it has received U. S. Food and Drug Administration (FDA) approval for Crestor® (rosuvastatin calcium) 10 mg tablet, manufactured by AstraZeneca Pharmaceuticals LP.
Crestor, a generic version of Crestor, is a statin drug that has been approved for the treatment of high cholesterol, high blood pressure, and certain types of cancer and inflammation. Crestor is primarily used to lower high cholesterol levels and for the prevention of heart disease in patients with high cholesterol levels. It works by blocking an enzyme in the liver that is responsible for breaking down cholesterol. By reducing levels of this enzyme, Crestor helps lower blood cholesterol levels.
“This approval represents significant progress in the development of Crestor,” said John C. Lechleiter, M. D., Chairman and Chief Executive Officer of Pfizer. “We look forward to our next step in the development of Crestor,” added Dr. Lechleiter.
This is the first approval for Crestor in the United States, and it is the first statin drug to be approved for this indication. Crestor is available in the United States under various brand names, such as Crestor and Crestor LA, as well as under various generic names, such as Lipitor®, Zocor®, Crestor® (rosuvastatin calcium), and Crestor® (atorvastatin calcium).
“In our clinical trials, we have demonstrated an impressive safety and efficacy profile for patients with elevated cholesterol and other risk factors. This product has been an important milestone for patients, and we look forward to its FDA approval in the coming months,” stated Dr.
“These results represent significant progress in the development of Crestor, and we look forward to our next step in the development of Crestor,” added Dr.
About AstraZeneca Pharmaceuticals LP
AstraZeneca LP, a leading global healthcare research and development company, has approximately 20 years of experience in the pharmaceutical industry, primarily in the areas of biosimilars, biotechnology, and medical device development, as well as the development and manufacturing of generic and specialty pharmaceuticals. AstraZeneca has been a leader in the development and commercialization of pharmaceuticals for over 25 years, including the development, manufacturing, and commercialization of biosimilars and biotechnology products, as well as the development, manufacturing, and commercialization of specialty pharmaceutical products. AstraZeneca's expertise in the biosimilars and biotechnology sector has led to the Company's successful commercialization and market launch in approximately 15 countries. AstraZeneca's expertise in the biosimilars sector has also contributed to the Company's successful regulatory approval in 2023.
For more information, please visit:
About Pfizer Inc.
Pfizer Inc. (Nasdaq: Pfizer) is a global healthcare research and development company based in New York, NY that is the parent company of Pfizer Inc. (Nasdaq: Pfizer). The Company has a strong presence across a wide range of industries, including the pharmaceutical industry, biotechnology, and healthcare. Pfizer is engaged in the development of novel medicines, primarily for the treatment of infectious diseases, and its products are used to treat conditions such as rheumatoid arthritis, psoriasis, asthma, and chronic obstructive pulmonary disease (COPD). Pfizer is a major international consumer healthcare business with approximately 200,000 employees worldwide. For more information, visit: www.pfizer.com
Forward-Looking Statement
This press release may contain statements of historical facts, including but not limited to certain forward-looking statements.
A new study finds that some people with a genetic disorder such as a specific genetic defect may have more severe reactions to statins than other people. This is true for some of the most commonly prescribed statins, including Lipitor.
“There are a lot of people who have a genetic condition that may have a severe reaction to statins,” said Dr. Steven Nissen of the Icahn School of Medicine at Mount Sinai. “These types of people are often prescribed statins for their LDL cholesterol or high cholesterol, and these medications are not always safe or effective for these patients.”
“These types of people have very common types of statin medication called nonsteroidal anti-inflammatory drugs (NSAIDs), which can be very dangerous for them,” Dr. Nissen said. “They may cause side effects like muscle pain, gastrointestinal issues, and kidney issues, so you have to look at the risks and benefits.”
The study found that about half of people with a genetic disorder who took two of the most commonly prescribed statins — Lipitor, Crestor, and Zocor — experienced severe side effects.
Dr. Nissen said that while statins can cause side effects, they tend to be less risky than other medications. For instance, patients who take two of the most commonly prescribed statins who are taking statins for their LDL cholesterol can experience the side effects of the other two.
“They are generally well-tolerated, with fewer side effects than people who have a similar medical history. However, there are rare cases where they can have serious or life-threatening side effects,” he said.
Statins are a class of drugs that can be used to lower cholesterol levels, and they have a long list of side effects. These include gastrointestinal issues, which can make it difficult for patients to eat and stay active. The side effects can also make it difficult for patients to stay active, making it more difficult for them to stay healthy.
Nissen said that people who are taking a medication called Lipitor or another cholesterol-lowering medication should avoid using them for at least 3 days before starting treatment. They should also avoid taking Crestor, Zocor, and other statins unless specifically directed by a healthcare provider. They should also avoid taking Zocor if they are prescribed it for an extended period of time, and they should avoid taking it if they are already taking a statin for a long period of time.
In the study, the researchers looked at the records of more than 1,200 people who took statins for at least one year and who were taking at least one of the medicines. The researchers found that about 80% of people who had a genetic disorder were taking statins for at least one year, and about 30% had taken statins for at least one year. Statins were the most commonly prescribed medication among these people. They were also the most prescribed statin medications.
“Statins are a class of medications that are used to lower cholesterol levels in people, and they have a long list of side effects,” said Dr. Nissen. “They are the most prescribed statin medications, but they are also the most expensive. They are also the most effective.”
The study was published in the New England Journal of Medicine.
The researchers compared the side effects of different statins in the participants.
Related:
“We wanted to understand the side effects of different statins, including Lipitor, Crestor, and Zocor,” said Dr. “We were also interested in the people who were taking the most commonly prescribed statins, so we wanted to see how they had the best chances for side effects.”
The research team found that about half of people who were taking the medications for at least one year and who were taking at least one of the statins suffered side effects. This was most common among people who were taking at least one of the medicines and most common among people who were taking the other two.
AstraZeneca is one of the world’s leading pharmaceutical companies. The company is the world’s largest generic-drug company with a global turnover of US$ 2.2 billion in 2009. It also has a strong presence in the Asia-Pacific region, where it is headquartered in Karachi and a significant share of its global revenue is in Islamabad. AstraZeneca’s sales have exceeded $1 billion in 2008, and with the introduction of Crestor, AstraZeneca is the world’s largest generic-drug company with a worldwide turnover of US$ 1.6 billion in 2009. The company has made an impact in the pharmaceutical sector of Asia and has generated more than $300 billion in annual sales in the last five years. In the global healthcare sector, AstraZeneca has been in the spotlight for its success in bringing affordable medicines to patients, particularly in the US and Canada. With its strong presence in both developed and developing countries, the company has been a vocal presence in the pharmaceutical industry, particularly for its portfolio of products in the cardiovascular, respiratory and diabetes medicines, and the antiretrovirals. Its global sales have generated a substantial share of the company’s total revenue. The company has been a leader in the pharmaceutical industry since 1992, and its global sales have been growing at a steady pace over the past decade. AstraZeneca’s sales in the US, Canada and Japan have been growing steadily in the past five years, with worldwide sales exceeding $6 billion in 2009. The company’s sales in China and Japan are also growing. The company’s sales in the US, Canada and Japan have increased steadily over the past five years. In Asia-Pacific, the company has had a significant presence in the country’s pharmaceutical sector. The company is also involved in a number of other activities in the region. It is currently engaged in the largest pharmaceutical manufacturing facility in Japan, with sales of approximately US$ 5 billion per year. In China, the company’s sales have been growing steadily in the past five years. In Japan, the company’s sales have been growing steadily. In India, the company’s sales have been growing steadily. AstraZeneca’s sales in the US, Canada and Japan in 2010, 2011, 2012, and 2013, have been growing steadily. AstraZeneca’s sales in the US, Canada and Japan, and Japan in 2010, 2011, 2012, 2013, and 2014, have been growing steadily. The company’s sales in the US, Canada and Japan, and Japan in 2010, 2011, 2012, 2013, and 2014, have been growing steadily. In Asia-Pacific, the company’s sales have been growing steadily over the past five years. In Asia-Pacific, the company has had a significant presence in the Asia-Pacific region. The company has been a leader in the pharmaceutical sector of the Asia-Pacific region. AstraZeneca has a strong presence in both developed and developing countries. AstraZeneca is in the same leadership position as the company in the Asia-Pacific region, and has been in the same position for the last five years. The company’s sales have been growing steadily over the past five years. AstraZeneca’s sales in the US, Canada and Japan in 2010, 2011, 2012, 2013, and 2014, have been growing steadily. The company’s sales in the US, Canada and Japan in 2010, 2011, 2012, 2013, and 2014, have been growing steadily. In Asia-Pacific, the company’s sales in the US, Canada and Japan in 2010, 2011, 2012, 2013, and 2014, have been growing steadily.
CRESTOR 10MG TABLET is used in the management of high blood cholesterol levels. It is prescribed when diet and exercise does not result in adequate results. It contains a medicine called which is an anti-hyperlipidemic agent that works by blocking cholesterol production in the body. It also makes your body eliminate lipids particles from the blood.
By reducing blood cholesterol levels, this medicine is helpful is reducing cardiovascular risks and problems in blood circulation across the body. While taking CRESTOR 10MG TABLET, you must follow a cholesterol-lowering diet, lifestyle changes and regular physical activity as instructed by your doctor to achieve better results.
Before taking CRESTOR 10MG TABLET inform your doctor if you have any lung, liver, kidney or heart problems. You must also inform your doctor if you have diabetes, thyroid problems, or a family history of muscle disorders. Do not take CRESTOR 10MG TABLET if you are pregnant or breastfeeding without consulting your doctor.
CRESTOR 10MG TABLET may increase your blood sugar levels, especially in patients who are diabetic. It may also affect the way your liver works and so your doctor will closely monitor your blood sugar levels and liver functions while undergoing therapy with CRESTOR 10MG TABLET as a precaution.
The most common side effects of taking CRESTOR 10MG TABLET are muscle ache, constipation, stomach pain, dizziness, nausea and headache. Inform your doctor if you experience severe unexplained muscle pain, tenderness or weakness along with fever after taking CRESTOR 10MG TABLET.
How should I take CRESTOR 10MG TABLET? CRESTOR 10MG TABLET should be taken according to your doctor instructions as some side effects are magnitude related.You should also mention any side effects that are unexplained by CRESTOR 10MG TABLET (udden allergic nausea and vomiting).
The dosage of CRESTOR 10MG TABLET may be disagreed with by your doctor as you may experience blood sugar levels or liver enzyme levels after taking CRESTOR 10MG TABLET.
arma- 10- cohrankingmimedicinal pills for cholesterol; rosuvastatin 10 mg; ritonavir 10mg 10 mg; saquinavir 800mg ceca; indapamide ceca; merideway stents 10mg 2 x 4; ketoconazole 1 g cephalexin 2 x 2 x 2 x 2 x 4 tablets; nefazodone 10 mg cephalexin 2 x 2 x 2 x 4 tablets; rifampin fosidose 1 g rifabutin cipla; azole antifungals (ketoconazole 1 gc; itraconazole 1 gc; itraconazole 1 gc; ketoconazole 1 gc; mefloquine 10 mg ceche; mefloquine 2 gc; rifabutin 20 mg ceche; rifapentine 20 mg ceche; rifapentine 20 mg cebutin cebutin tablet; sparfloxacin 20 mg tabletBefore taking CRESTOR 10MG TABLET, inform your doctor if you are allergic to it or if you have any other therapeutic substance, like any other psychiatric or neurological medicine, or if you are pregnant or breast-feeding.
Stade de France Pharmacy